CEFOXITIN

CEFOXITIN was reported 1390 times

CEFOXITIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OTITIS MEDIA FUNGAL 3 0.2727
1 MAMMARY FISTULA 1 0.1111
2 ANTIMICROBIAL SUSCEPTIBILITY TEST INTERMEDIATE 1 0.0909
3 MYCOBACTERIUM ABSCESSUS INFECTION 43 0.0601
4 AURICULAR PERICHONDRITIS 1 0.0526
5 SYSTEMIC MASTOCYTOSIS 15 0.0498
6 NORMAL LABOUR 6 0.0429
7 BRONCHIAL ANASTOMOSIS COMPLICATION 1 0.0417
8 ONYCHOGRYPHOSIS 1 0.0400
9 ACUTE HAEMOLYTIC TRANSFUSION REACTION 1 0.0357
10 GASTROSTOMY FAILURE 1 0.0323
11 MYCOBACTERIAL PERITONITIS 3 0.0316
12 PYOMETRA 2 0.0286
13 NEONATAL CHOLESTASIS 2 0.0238
14 ATYPICAL MYCOBACTERIUM TEST POSITIVE 2 0.0206
15 PENILE OPERATION 1 0.0204
16 BLOOD CREATINE PHOSPHOKINASE MB ABNORMAL 1 0.0185
17 HYPERGEUSIA 1 0.0169
18 NEUROSENSORY HYPOACUSIS 2 0.0165
19 MYCOBACTERIUM CHELONAE INFECTION 12 0.0162
20 OTOTOXICITY 29 0.0157
21 CORYNEBACTERIUM SEPSIS 1 0.0152
22 MYRINGITIS 1 0.0135
23 PERICARDIAL CYST 1 0.0130
24 INGUINAL HERNIA, OBSTRUCTIVE 1 0.0125
25 NEOVASCULARISATION 3 0.0114
26 POSTOPERATIVE THORACIC PROCEDURE COMPLICATION 1 0.0103
27 PROBIOTIC THERAPY 1 0.0101
28 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 1 0.0098
29 DELIVERY 6 0.0091
30 CHLAMYDIA TEST POSITIVE 1 0.0088
31 CEREBRAL VASCULAR OCCLUSION 1 0.0087
32 COMPLICATED APPENDICITIS 1 0.0085
33 ANAPHYLACTOID SHOCK 4 0.0085
34 INCARCERATED INGUINAL HERNIA 1 0.0082
35 BURKHOLDERIA TEST POSITIVE 1 0.0081
36 ANGULAR CHEILITIS 5 0.0072
37 METASTASES TO BLADDER 2 0.0070
38 PERINEPHRIC COLLECTION 1 0.0070
39 HYPERBILIRUBINAEMIA NEONATAL 4 0.0069
40 CYSTIC FIBROSIS RELATED DIABETES 1 0.0068
41 RASH FOLLICULAR 1 0.0065
42 NEONATAL TACHYCARDIA 1 0.0065
43 FOETAL GROWTH ABNORMALITY 1 0.0064
44 ACID FAST BACILLI INFECTION 1 0.0062
45 BLADDER CYST 1 0.0062
46 INFLAMMATION OF WOUND 2 0.0060
47 BRAIN MASS 2 0.0059
48 ANAEMIA OF PREGNANCY 1 0.0058
49 PH URINE INCREASED 1 0.0058
50 AMNIOTIC CAVITY INFECTION 4 0.0055
51 CUTANEOUS TUBERCULOSIS 1 0.0055
52 MYCOBACTERIUM FORTUITUM INFECTION 1 0.0054
53 HYDROCHOLECYSTIS 1 0.0054
54 PERSEVERATION 1 0.0054
55 LARYNGEAL STENOSIS 3 0.0052
56 GALLBLADDER PERFORATION 2 0.0052
57 ACINETOBACTER TEST POSITIVE 1 0.0052
58 JEJUNAL ULCER 1 0.0050
59 MYCOBACTERIUM TEST POSITIVE 1 0.0049
60 ENTEROBACTER INFECTION 8 0.0048
61 RENAL VESSEL DISORDER 1 0.0047
62 HISTAMINE LEVEL INCREASED 1 0.0046
63 RASH SCARLATINIFORM 1 0.0045
64 REFUSAL OF TREATMENT BY RELATIVE 2 0.0044
65 CORONARY ANGIOPLASTY 2 0.0044
66 LOCKED-IN SYNDROME 2 0.0043
67 POST PROCEDURAL PULMONARY EMBOLISM 1 0.0043
68 GRANULOMATOUS DERMATITIS 1 0.0041
69 DRUG-DISEASE INTERACTION 3 0.0041
70 KERATOSIS PILARIS 1 0.0040
71 INGUINAL MASS 1 0.0039
72 MICROSCOPIC POLYANGIITIS 1 0.0039
73 ADAMTS13 ACTIVITY DECREASED 1 0.0039
74 BODY TEMPERATURE 1 0.0037
75 BURSITIS INFECTIVE 2 0.0037
76 OSTEOMYELITIS BACTERIAL 1 0.0036
77 DISEASE SUSCEPTIBILITY 1 0.0036
78 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
79 MYCOBACTERIAL INFECTION 6 0.0035
80 RELAPSING FEVER 1 0.0035
81 HYPOURICAEMIA 1 0.0034
82 GALLBLADDER OEDEMA 1 0.0034
83 INJECTION SITE CYST 1 0.0034
84 URETHRAL HAEMORRHAGE 2 0.0033
85 DRUG RESISTANCE 85 0.0033
86 ASPERGILLUS TEST POSITIVE 1 0.0032
87 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
88 POST PROCEDURAL BILE LEAK 1 0.0032
89 SALPINGITIS 1 0.0031
90 PSEUDOCYST 1 0.0031
91 RED BLOOD CELLS URINE POSITIVE 3 0.0031
92 RED BLOOD CELL SCHISTOCYTES PRESENT 1 0.0031
93 LYMPHOCELE 2 0.0030
94 ILEOSTOMY CLOSURE 1 0.0030
95 MASS EXCISION 1 0.0029
96 PROTHROMBIN LEVEL INCREASED 1 0.0029
97 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 74 0.0029
98 LORDOSIS 1 0.0028
99 SUSPICIOUSNESS 2 0.0028
100 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
101 PANCREATIC INSUFFICIENCY 1 0.0028
102 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
103 PATHOGEN RESISTANCE 25 0.0027
104 ESCHAR 2 0.0027
105 DEAFNESS NEUROSENSORY 9 0.0027
106 ECLAMPSIA 1 0.0027
107 ANASTOMOTIC STENOSIS 1 0.0027
108 SERRATIA INFECTION 2 0.0027
109 MIXED LIVER INJURY 8 0.0027
110 NEGATIVISM 2 0.0026
111 EXTRADURAL ABSCESS 2 0.0025
112 LABORATORY TEST INTERFERENCE 2 0.0025
113 PSYCHOMOTOR RETARDATION 7 0.0025
114 EXCESSIVE GRANULATION TISSUE 2 0.0025
115 BONE ABSCESS 1 0.0025
116 NEONATAL TACHYPNOEA 1 0.0024
117 PERICARDITIS CONSTRICTIVE 1 0.0024
118 NAIL BED DISORDER 1 0.0023
119 ALLERGIC SINUSITIS 2 0.0023
120 HENOCH-SCHONLEIN PURPURA 5 0.0023
121 CATATONIA 12 0.0023
122 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2 0.0022
123 CATHETER SITE RASH 1 0.0022
124 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
125 INCISION SITE ERYTHEMA 1 0.0022
126 GALLBLADDER RUPTURE 1 0.0022
127 PELVIC INFECTION 1 0.0022
128 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
129 SKIN CANDIDA 1 0.0019
130 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
131 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
132 OSTEOMYELITIS ACUTE 1 0.0018
133 BRONCHOSTENOSIS 1 0.0018
134 ACINETOBACTER INFECTION 2 0.0018
135 PNEUMONIA STREPTOCOCCAL 2 0.0018
136 HELICOBACTER TEST POSITIVE 1 0.0018
137 POSTOPERATIVE ILEUS 1 0.0018
138 PELVIC ABSCESS 2 0.0017
139 NASAL MUCOSAL DISORDER 1 0.0017
140 RASH MACULO-PAPULAR 38 0.0017
141 ANAPHYLACTOID REACTION 7 0.0017
142 TETANY 3 0.0016
143 PARADOXICAL DRUG REACTION 6 0.0016
144 MULTIPLE-DRUG RESISTANCE 5 0.0016
145 PSOAS ABSCESS 1 0.0016
146 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
147 ENTEROCOCCUS TEST POSITIVE 1 0.0015
148 ABDOMINAL WALL ABSCESS 1 0.0015
149 KLEBSIELLA TEST POSITIVE 1 0.0015
150 INTERNAL INJURY 1 0.0015
151 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
152 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
153 PLEURAL THICKENING 1 0.0015
154 GENITAL SWELLING 1 0.0014
155 HAEMODYNAMIC INSTABILITY 11 0.0014
156 GRAVITATIONAL OEDEMA 1 0.0014
157 BRONCHIAL OBSTRUCTION 2 0.0014
158 PROPOFOL INFUSION SYNDROME 1 0.0014
159 LOW BIRTH WEIGHT BABY 11 0.0014
160 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
161 GASTRIC MUCOSAL LESION 1 0.0014
162 DIET REFUSAL 1 0.0014
163 SCOTOMA 1 0.0014
164 RESPIRATORY TRACT OEDEMA 1 0.0013
165 PSEUDOMEMBRANOUS COLITIS 3 0.0013
166 BRONCHIECTASIS 9 0.0013
167 MICTURITION FREQUENCY DECREASED 1 0.0013
168 GINGIVAL ABSCESS 1 0.0013
169 MULTIPLE DRUG THERAPY 1 0.0013
170 CAUDA EQUINA SYNDROME 1 0.0013
171 GASTROINTESTINAL SURGERY 1 0.0013
172 DEBRIDEMENT 1 0.0013
173 MYASTHENIC SYNDROME 1 0.0013
174 INJECTION SITE BURNING 1 0.0013
175 GRIMACING 1 0.0013
176 MEGACOLON 2 0.0013
177 IMPLANT SITE EXTRAVASATION 1 0.0013
178 BLOOD FIBRINOGEN INCREASED 1 0.0013
179 PREMATURE RUPTURE OF MEMBRANES 3 0.0012
180 ENDOMETRIAL HYPERPLASIA 1 0.0012
181 SEPSIS NEONATAL 1 0.0012
182 LEUKOCYTOCLASTIC VASCULITIS 2 0.0012
183 PSEUDOMONAS TEST POSITIVE 1 0.0012
184 RENAL ABSCESS 1 0.0012
185 LEUKOCYTURIA 1 0.0012
186 SEPTIC EMBOLUS 1 0.0012
187 EOSINOPHILIA 21 0.0012
188 CULTURE POSITIVE 1 0.0012
189 SYSTEMIC CANDIDA 3 0.0012
190 FRACTURE DELAYED UNION 1 0.0012
191 WOUND DEHISCENCE 4 0.0012
192 HEPATITIS A 1 0.0012
193 DEAFNESS BILATERAL 2 0.0012
194 NEPHROPATHY TOXIC 13 0.0012
195 PULMONARY CAVITATION 1 0.0011
196 ARTERIAL STENOSIS 1 0.0011
197 TYPE I HYPERSENSITIVITY 4 0.0011
198 BLOOD ALBUMIN INCREASED 1 0.0011
199 PROTEIN URINE 1 0.0011
200 PRIMARY SEQUESTRUM 1 0.0011
201 SOFT TISSUE INFECTION 2 0.0011
202 RASH MORBILLIFORM 3 0.0011
203 HEPATITIS ACUTE 7 0.0011
204 RENAL TUBULAR DISORDER 3 0.0011
205 CIRCULATORY COLLAPSE 18 0.0011
206 HYPERCOAGULATION 2 0.0010
207 SKIN HYPERPIGMENTATION 9 0.0010
208 RETINAL VEIN OCCLUSION 3 0.0010
209 CROSS SENSITIVITY REACTION 1 0.0010
210 BONE MARROW DEPRESSION 1 0.0010
211 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
212 IDIOSYNCRATIC DRUG REACTION 1 0.0010
213 PULMONARY MASS 15 0.0010
214 HYPERTRANSAMINASAEMIA 7 0.0010
215 BLADDER CANCER RECURRENT 1 0.0010
216 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
217 HYPERBILIRUBINAEMIA 10 0.0010
218 SKIN INDURATION 2 0.0010
219 POST LUMBAR PUNCTURE SYNDROME 1 0.0010
220 ENTEROCOCCAL BACTERAEMIA 1 0.0009
221 PREMATURE DELIVERY 15 0.0009
222 GALLBLADDER ENLARGEMENT 1 0.0009
223 FACIAL PALSY 2 0.0009
224 BLADDER DILATATION 1 0.0009
225 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
226 ATRIAL FLUTTER 7 0.0009
227 PULMONARY GRANULOMA 1 0.0009
228 BILIRUBIN CONJUGATED INCREASED 2 0.0009
229 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 2 0.0009
230 ANAPHYLACTIC SHOCK 22 0.0009
231 HEPATOCELLULAR INJURY 12 0.0008
232 ACUTE LUNG INJURY 1 0.0008
233 DEAFNESS 22 0.0008
234 ESCHERICHIA TEST POSITIVE 1 0.0008
235 BRONCHIAL HYPERREACTIVITY 1 0.0008
236 REFLUX GASTRITIS 1 0.0008
237 PRODUCT PACKAGING CONFUSION 2 0.0008
238 BRONCHITIS CHRONIC 2 0.0008
239 OTITIS EXTERNA 1 0.0008
240 CYTOPENIA 10 0.0008
241 PALATAL OEDEMA 1 0.0008
242 BLOOD UREA DECREASED 1 0.0008
243 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
244 LUNG INFILTRATION 7 0.0008
245 KLEBSIELLA INFECTION 4 0.0008
246 GASTRIC ULCER PERFORATION 1 0.0008
247 SEROMA 1 0.0008
248 HYPERTHERMIA 6 0.0008
249 BRONCHIAL SECRETION RETENTION 1 0.0008
250 SCREAMING 5 0.0008
251 CARDIOPULMONARY FAILURE 3 0.0008
252 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
253 NON-HODGKIN'S LYMPHOMA 1 0.0008
254 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
255 BLOOD ALBUMIN DECREASED 6 0.0008
256 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
257 ARTHRITIS BACTERIAL 3 0.0007
258 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
259 RENAL ARTERY STENOSIS 1 0.0007
260 CYSTIC FIBROSIS 4 0.0007
261 PERITONEAL HAEMORRHAGE 1 0.0007
262 ECHOCARDIOGRAM ABNORMAL 1 0.0007
263 MAST CELL ACTIVATION SYNDROME 1 0.0007
264 PRERENAL FAILURE 1 0.0007
265 LIP OEDEMA 3 0.0007
266 CHOLECYSTITIS ACUTE 4 0.0007
267 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
268 MUTISM 1 0.0007
269 PULMONARY SEPSIS 1 0.0007
270 ANAPHYLACTIC REACTION 38 0.0007
271 PULMONARY PAIN 2 0.0007
272 NEUROTOXICITY 12 0.0007
273 PANCREATIC ENZYMES INCREASED 1 0.0007
274 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
275 BLOOD CREATINE INCREASED 3 0.0007
276 GENITAL PAIN 1 0.0007
277 CHOLANGIOCARCINOMA 1 0.0007
278 MYOCLONUS 8 0.0007
279 PELVIC INFLAMMATORY DISEASE 1 0.0007
280 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
281 MARASMUS 1 0.0007
282 FOETAL GROWTH RESTRICTION 4 0.0007
283 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
284 RUBBER SENSITIVITY 1 0.0007
285 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
286 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
287 FUNGAEMIA 1 0.0006
288 INHIBITORY DRUG INTERACTION 1 0.0006
289 PRE-ECLAMPSIA 3 0.0006
290 PULSE ABSENT 3 0.0006
291 BRONCHOSPASM 9 0.0006
292 INTESTINAL ULCER 1 0.0006
293 LIMB DEFORMITY 1 0.0006
294 SUBCUTANEOUS ABSCESS 3 0.0006
295 PANCREATITIS ACUTE 14 0.0006
296 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
297 TENDON DISORDER 4 0.0006
298 PROTEIN URINE PRESENT 3 0.0006
299 HEPATIC ENZYME ABNORMAL 3 0.0006
300 LINEAR IGA DISEASE 1 0.0006
301 PREMATURE BABY 18 0.0006
302 CHOLECYSTITIS CHRONIC 4 0.0006
303 CHOLECYSTITIS 7 0.0006
304 WOUND COMPLICATION 2 0.0006
305 FIXED ERUPTION 1 0.0006
306 BLOOD CHLORIDE INCREASED 1 0.0006
307 PSEUDOMONAL SEPSIS 1 0.0006
308 BREAST DISCHARGE 1 0.0006
309 ENCEPHALOPATHY 14 0.0006
310 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
311 TENDON RUPTURE 7 0.0006
312 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
313 FIBRIN D DIMER INCREASED 2 0.0006
314 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
315 BONE LESION 2 0.0006
316 BLOOD PHOSPHORUS DECREASED 2 0.0005
317 PNEUMONIA BACTERIAL 5 0.0005
318 HYPERKERATOSIS 3 0.0005
319 LOBAR PNEUMONIA 1 0.0005
320 NECROSIS 3 0.0005
321 LYMPH NODE PAIN 1 0.0005
322 BLOOD IRON INCREASED 1 0.0005
323 JAUNDICE NEONATAL 1 0.0005
324 MECHANICAL VENTILATION 1 0.0005
325 ATELECTASIS 5 0.0005
326 RALES 3 0.0005
327 PURULENCE 1 0.0005
328 ABDOMINAL WALL HAEMATOMA 1 0.0005
329 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
330 BICYTOPENIA 1 0.0005
331 RESPIRATORY ACIDOSIS 2 0.0005
332 DIPLEGIA 1 0.0005
333 ANORECTAL DISORDER 1 0.0005
334 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
335 OSTEOLYSIS 1 0.0005
336 DIVERTICULAR PERFORATION 1 0.0005
337 RENAL MASS 1 0.0005
338 LUNG ABSCESS 1 0.0005
339 OPTIC NEUROPATHY 1 0.0005
340 OCCUPATIONAL EXPOSURE TO PRODUCT 3 0.0005
341 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
342 PULMONARY FUNCTION TEST DECREASED 2 0.0005
343 THROMBOCYTOPENIA 51 0.0005
344 HAEMORRHAGIC ANAEMIA 2 0.0005
345 NOSOCOMIAL INFECTION 1 0.0005
346 CLOSTRIDIUM TEST POSITIVE 1 0.0005
347 SOPOR 6 0.0005
348 CARDIAC FAILURE ACUTE 3 0.0004
349 TRANSAMINASES INCREASED 10 0.0004
350 POSTOPERATIVE WOUND INFECTION 3 0.0004
351 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
352 VASCULAR DEVICE INFECTION 2 0.0004
353 HAEMATOCRIT INCREASED 1 0.0004
354 METHAEMOGLOBINAEMIA 1 0.0004
355 CARDIO-RESPIRATORY ARREST 18 0.0004
356 HEPATITIS 11 0.0004
357 SINUS TACHYCARDIA 6 0.0004
358 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
359 GASTROINTESTINAL OBSTRUCTION 1 0.0004
360 DIABETES INSIPIDUS 1 0.0004
361 ENTEROCOCCAL INFECTION 2 0.0004
362 HAEMATOLOGICAL INFECTION 1 0.0004
363 BREATH SOUNDS ABNORMAL 2 0.0004
364 DENTAL OPERATION 1 0.0004
365 ORGANISING PNEUMONIA 2 0.0004
366 GASTROINTESTINAL TUBE INSERTION 1 0.0004
367 DERMATITIS EXFOLIATIVE 2 0.0004
368 HYPERPARATHYROIDISM SECONDARY 1 0.0004
369 TREATMENT FAILURE 33 0.0004
370 INTENTIONAL SELF-INJURY 8 0.0004
371 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
372 DRUG ERUPTION 7 0.0004
373 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
374 ACIDOSIS 3 0.0004
375 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
376 LEUKOCYTOSIS 7 0.0004
377 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
378 ABDOMINAL MASS 1 0.0004
379 HYPERLACTACIDAEMIA 1 0.0004
380 RENAL INJURY 11 0.0004
381 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
382 ESCHERICHIA INFECTION 3 0.0004
383 EMBOLISM 3 0.0004
384 MACULE 1 0.0004
385 BLOOD UREA INCREASED 6 0.0004
386 MALNUTRITION 4 0.0004
387 LUNG CONSOLIDATION 1 0.0004
388 ELECTRIC SHOCK SENSATION 1 0.0004
389 ENDOTRACHEAL INTUBATION 1 0.0004
390 CANDIDA INFECTION 6 0.0004
391 UTERINE PERFORATION 3 0.0004
392 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
393 RESPIRATORY SYMPTOM 1 0.0004
394 NEUTROPHILIA 2 0.0004
395 DUODENAL ULCER HAEMORRHAGE 1 0.0003
396 ADENOVIRUS INFECTION 1 0.0003
397 HAEMOTHORAX 1 0.0003
398 PRODUCT LABEL CONFUSION 2 0.0003
399 DRUG INTOLERANCE 33 0.0003
400 CARDIOMYOPATHY 5 0.0003
401 BACTERAEMIA 4 0.0003
402 CREPITATIONS 1 0.0003
403 HAEMOLYTIC ANAEMIA 3 0.0003
404 BRAIN HERNIATION 1 0.0003
405 BLOOD CULTURE POSITIVE 1 0.0003
406 STAPHYLOCOCCAL INFECTION 11 0.0003
407 ACNE CYSTIC 1 0.0003
408 HYPERCAPNIA 1 0.0003
409 HEPATITIS B 2 0.0003
410 CENTRAL VENOUS CATHETERISATION 1 0.0003
411 OSTEOMYELITIS 6 0.0003
412 BONE MARROW DISORDER 1 0.0003
413 REBOUND ACID HYPERSECRETION 1 0.0003
414 RENAL FAILURE ACUTE 14 0.0003
415 EMERGENCY CARE 1 0.0003
416 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
417 MEDICAL DEVICE DISCOMFORT 1 0.0003
418 RECTAL CANCER 1 0.0003
419 CARDIOMEGALY 4 0.0003
420 GRAND MAL CONVULSION 3 0.0003
421 DEVICE RELATED INFECTION 5 0.0003
422 BRAIN DEATH 1 0.0003
423 HAEMOPTYSIS 9 0.0003
424 ERYTHEMA MULTIFORME 3 0.0003
425 FLANK PAIN 3 0.0003
426 ABDOMINAL ADHESIONS 1 0.0003
427 BILE DUCT STONE 1 0.0003
428 POST PROCEDURAL COMPLICATION 6 0.0003
429 CUSHINGOID 1 0.0003
430 LIVER ABSCESS 1 0.0003
431 LYMPHOCYTE COUNT INCREASED 1 0.0003
432 ASPERGILLUS INFECTION 2 0.0003
433 LISTLESS 1 0.0003
434 PEPTIC ULCER 1 0.0003
435 CYTOLYTIC HEPATITIS 1 0.0003
436 PLANTAR FASCIITIS 1 0.0003
437 EMPHYSEMA 3 0.0003
438 JAUNDICE 8 0.0003
439 CLOSTRIDIAL INFECTION 1 0.0003
440 HEPATIC CYST 1 0.0003
441 TACHYPNOEA 4 0.0003
442 PALLOR 8 0.0003
443 NEUTROPHIL COUNT INCREASED 3 0.0003
444 LEFT VENTRICULAR FAILURE 1 0.0003
445 GRANULOMA 1 0.0003
446 DRUG-INDUCED LIVER INJURY 9 0.0003
447 ERYTHEMA NODOSUM 1 0.0003
448 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
449 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
450 LUNG TRANSPLANT 1 0.0003
451 CARDIAC ARREST 23 0.0003
452 HYPOKINESIA 4 0.0003
453 WOUND INFECTION 3 0.0003
454 UNRESPONSIVE TO STIMULI 7 0.0003
455 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
456 BACTERIAL INFECTION 5 0.0003
457 CHRONIC SINUSITIS 1 0.0003
458 PROTEIN TOTAL DECREASED 1 0.0003
459 PANCREATITIS 14 0.0003
460 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
461 DERMATITIS CONTACT 3 0.0003
462 TROPONIN INCREASED 2 0.0003
463 PARANASAL SINUS HYPERSECRETION 1 0.0003
464 PROCEDURAL COMPLICATION 2 0.0003
465 GINGIVAL DISORDER 1 0.0003
466 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
467 TACHYCARDIA 23 0.0003
468 TENDONITIS 4 0.0003
469 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
470 POST PROCEDURAL HAEMORRHAGE 3 0.0003
471 HYPOXIA 9 0.0003
472 HALLUCINATION, AUDITORY 4 0.0003
473 EXPOSURE VIA BREAST MILK 1 0.0003
474 MUSCLE RIGIDITY 3 0.0003
475 ABSCESS 4 0.0003
476 PANCYTOPENIA 14 0.0003
477 OBSTRUCTION 1 0.0003
478 PRODUCT USE IN UNAPPROVED INDICATION 62 0.0002
479 TRANSPLANT REJECTION 2 0.0002
480 CANDIDIASIS 1 0.0002
481 GOITRE 1 0.0002
482 DEMYELINATION 1 0.0002
483 CHOLELITHIASIS 8 0.0002
484 DRUG LEVEL INCREASED 4 0.0002
485 CYTOMEGALOVIRUS INFECTION 4 0.0002
486 EOSINOPHIL COUNT INCREASED 2 0.0002
487 PERICARDITIS 4 0.0002
488 INTESTINAL STENOSIS 1 0.0002
489 SKIN PLAQUE 2 0.0002
490 HYPERPYREXIA 1 0.0002
491 ABSCESS LIMB 1 0.0002
492 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
493 LUNG NEOPLASM 1 0.0002
494 PULMONARY TUBERCULOSIS 1 0.0002
495 PURULENT DISCHARGE 1 0.0002
496 OCULAR ICTERUS 1 0.0002
497 SEPTIC SHOCK 10 0.0002
498 DIVERTICULUM INTESTINAL 1 0.0002
499 ONYCHOMYCOSIS 1 0.0002
500 IMMUNOSUPPRESSION 2 0.0002
501 LYMPHOCYTE COUNT DECREASED 4 0.0002
502 ABDOMINAL ABSCESS 1 0.0002
503 PURPURA 2 0.0002
504 FEAR 6 0.0002
505 ACUTE KIDNEY INJURY 34 0.0002
506 PAPILLOEDEMA 1 0.0002
507 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
508 DRUG EFFECT DELAYED 1 0.0002
509 LEUKOPENIA 11 0.0002
510 HYPERGLYCAEMIA 8 0.0002
511 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
512 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
513 DYSPAREUNIA 1 0.0002
514 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
515 NEPHROGENIC ANAEMIA 1 0.0002
516 INTERCEPTED MEDICATION ERROR 1 0.0002
517 ARTHRITIS INFECTIVE 1 0.0002
518 HYPOMAGNESAEMIA 3 0.0002
519 ROSACEA 1 0.0002
520 BLOOD CREATININE INCREASED 14 0.0002
521 APPENDICITIS 2 0.0002
522 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
523 SKIN ABRASION 1 0.0002
524 DISEASE RECURRENCE 10 0.0002
525 ENDOMETRIOSIS 1 0.0002
526 HYPOACUSIS 9 0.0002
527 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
528 GASTROINTESTINAL TOXICITY 1 0.0002
529 ACUTE RESPIRATORY FAILURE 4 0.0002
530 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
531 HYPOGLYCAEMIA 10 0.0002
532 RENAL CELL CARCINOMA 1 0.0002
533 RENAL TUBULAR NECROSIS 2 0.0002
534 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
535 HYPERVOLAEMIA 1 0.0002
536 LIGAMENT SPRAIN 2 0.0002
537 ABDOMINAL TENDERNESS 1 0.0002
538 HYPERNATRAEMIA 1 0.0002
539 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
540 NEUROPATHY PERIPHERAL 19 0.0002
541 TOXIC SKIN ERUPTION 2 0.0002
542 PERITONITIS BACTERIAL 2 0.0002
543 TINNITUS 9 0.0002
544 SKIN DISCOLOURATION 9 0.0002
545 ENDOCARDITIS 1 0.0002
546 INCREASED UPPER AIRWAY SECRETION 1 0.0002
547 CACHEXIA 1 0.0002
548 FOETAL DEATH 1 0.0002
549 FAILURE TO THRIVE 1 0.0002
550 VENTRICULAR EXTRASYSTOLES 2 0.0002
551 CYANOSIS 3 0.0002
552 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
553 RENAL IMPAIRMENT 16 0.0002
554 SERUM FERRITIN INCREASED 1 0.0002
555 HALLUCINATION, VISUAL 4 0.0002
556 HYPOTENSION 38 0.0002
557 RENAL FAILURE 25 0.0002
558 LACTIC ACIDOSIS 6 0.0002
559 CHEILITIS 1 0.0002
560 NORMAL NEWBORN 1 0.0002
561 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
562 DEAFNESS UNILATERAL 1 0.0002
563 CHOKING SENSATION 1 0.0002
564 RESPIRATORY DISTRESS 5 0.0002
565 FUNGAL INFECTION 6 0.0002
566 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
567 ANGIOPATHY 1 0.0002
568 SKIN INFECTION 2 0.0002
569 STATUS EPILEPTICUS 2 0.0002
570 EXPOSURE DURING PREGNANCY 11 0.0002
571 HEPATIC ENZYME INCREASED 12 0.0002
572 GRANULOCYTOPENIA 1 0.0002
573 SCAR 3 0.0002
574 CARDIAC VALVE DISEASE 1 0.0002
575 CONDITION AGGRAVATED 53 0.0002
576 PARANOIA 3 0.0002
577 EXERCISE TOLERANCE DECREASED 1 0.0002
578 VASCULITIS 2 0.0002
579 HYPERTRIGLYCERIDAEMIA 1 0.0002
580 COLD SWEAT 3 0.0002
581 BRADYCARDIA 9 0.0002
582 DECREASED INTEREST 1 0.0002
583 GALLBLADDER DISORDER 3 0.0002
584 PROTHROMBIN TIME PROLONGED 1 0.0002
585 HEARING IMPAIRED 1 0.0002
586 HEPATITIS C 2 0.0002
587 SMALL INTESTINAL OBSTRUCTION 2 0.0002
588 SCOLIOSIS 1 0.0002
589 AGRANULOCYTOSIS 3 0.0002
590 CHOLANGITIS 1 0.0002
591 HYPOCALCAEMIA 3 0.0002
592 HEPATIC CYTOLYSIS 2 0.0002
593 CHOLESTASIS 3 0.0002
594 RASH 68 0.0002
595 HERPES SIMPLEX 1 0.0002
596 PULMONARY CONGESTION 2 0.0002
597 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
598 APPETITE DISORDER 1 0.0002
599 RESPIRATORY FAILURE 11 0.0002
600 AGITATION 11 0.0001
601 BREAST MASS 1 0.0001
602 BLOOD BILIRUBIN INCREASED 4 0.0001
603 HAEMATURIA 5 0.0001
604 SKIN LESION 4 0.0001
605 GASTROINTESTINAL DISORDER 13 0.0001
606 ENCEPHALITIS 1 0.0001
607 SEPSIS 16 0.0001
608 COORDINATION ABNORMAL 2 0.0001
609 DERMATITIS 3 0.0001
610 WOUND 4 0.0001
611 LUNG DISORDER 7 0.0001
612 OXYGEN SATURATION DECREASED 8 0.0001
613 PAPULE 1 0.0001
614 HAND FRACTURE 1 0.0001
615 RETCHING 3 0.0001
616 LIVER FUNCTION TEST INCREASED 3 0.0001
617 CARDIOGENIC SHOCK 2 0.0001
618 LIVER FUNCTION TEST ABNORMAL 4 0.0001
619 FLUID OVERLOAD 2 0.0001
620 MOUTH HAEMORRHAGE 1 0.0001
621 STEVENS-JOHNSON SYNDROME 3 0.0001
622 HEPATOTOXICITY 3 0.0001
623 DUODENAL ULCER PERFORATION 1 0.0001
624 RASH PAPULAR 3 0.0001
625 ECZEMA 7 0.0001
626 HYDRONEPHROSIS 1 0.0001
627 HYPOAESTHESIA ORAL 2 0.0001
628 LIPASE INCREASED 1 0.0001
629 PHARYNGEAL OEDEMA 2 0.0001
630 PERICARDIAL EFFUSION 3 0.0001
631 HAEMOLYSIS 1 0.0001
632 OEDEMA 7 0.0001
633 DELUSION 2 0.0001
634 LUNG INFECTION 2 0.0001
635 APNOEA 1 0.0001
636 THERAPY PARTIAL RESPONDER 2 0.0001
637 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
638 PNEUMOTHORAX 2 0.0001
639 COMA 6 0.0001
640 RENAL CYST 1 0.0001
641 GINGIVAL PAIN 1 0.0001
642 MUSCLE DISORDER 1 0.0001
643 POST PROCEDURAL INFECTION 1 0.0001
644 METASTASES TO BONE 2 0.0001
645 PYREXIA 42 0.0001
646 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
647 SECOND PRIMARY MALIGNANCY 1 0.0001
648 HAEMODIALYSIS 1 0.0001
649 NEUTROPENIA 16 0.0001
650 PSEUDOMONAS INFECTION 1 0.0001
651 ABDOMINAL PAIN 27 0.0001
652 PSYCHOLOGICAL TRAUMA 1 0.0001
653 PYELONEPHRITIS 1 0.0001
654 BLOOD CALCIUM INCREASED 1 0.0001
655 METASTASES TO LIVER 2 0.0001
656 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
657 LYMPHADENOPATHY 4 0.0001
658 ISCHAEMIC STROKE 2 0.0001
659 PULMONARY OEDEMA 5 0.0001
660 OPTIC NEURITIS 1 0.0001
661 C-REACTIVE PROTEIN INCREASED 4 0.0001
662 BONE DISORDER 2 0.0001
663 END STAGE RENAL DISEASE 2 0.0001
664 EXOSTOSIS 1 0.0001
665 RESPIRATORY ARREST 3 0.0001
666 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
667 HYPOKALAEMIA 5 0.0001
668 DIVERTICULITIS 3 0.0001
669 PROCEDURAL PAIN 3 0.0001
670 PRODUCT DISTRIBUTION ISSUE 1 0.0001
671 HEPATIC STEATOSIS 2 0.0001
672 HEPATIC FUNCTION ABNORMAL 4 0.0001
673 HEPATIC ENCEPHALOPATHY 1 0.0001
674 NEPHROPATHY 1 0.0001
675 DIARRHOEA HAEMORRHAGIC 1 0.0001
676 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
677 SLEEP APNOEA SYNDROME 2 0.0001
678 SEROTONIN SYNDROME 2 0.0001
679 HYPERCHOLESTEROLAEMIA 1 0.0001
680 AUTOIMMUNE DISORDER 1 0.0001
681 CHEST PAIN 19 0.0001
682 ASCITES 3 0.0001
683 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
684 OVARIAN CYST 1 0.0001
685 SALIVARY HYPERSECRETION 1 0.0001
686 IRRITABILITY 6 0.0001
687 BRAIN INJURY 1 0.0001
688 ANAEMIA 19 0.0001
689 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
690 CELLULITIS 5 0.0001
691 HYPOTHERMIA 1 0.0001
692 FEEDING DISORDER 2 0.0001
693 BONE MARROW FAILURE 2 0.0001
694 DRUG LEVEL DECREASED 1 0.0001
695 CHEST DISCOMFORT 10 0.0001
696 EYE DISCHARGE 1 0.0001
697 INCONTINENCE 1 0.0001
698 RASH PRURITIC 5 0.0001
699 CHRONIC KIDNEY DISEASE 7 0.0001
700 OESOPHAGITIS 1 0.0001
701 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
702 ASPIRATION 1 0.0001
703 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
704 LIP SWELLING 3 0.0001
705 NERVE INJURY 1 0.0001
706 HYPERTENSIVE CRISIS 1 0.0001
707 INTESTINAL PERFORATION 1 0.0001
708 OFF LABEL USE 78 0.0001
709 FISTULA 1 0.0001
710 HYPONATRAEMIA 5 0.0001
711 CHROMATURIA 2 0.0001
712 CHOLECYSTECTOMY 1 0.0001
713 NAUSEA 69 0.0001
714 SHOCK 2 0.0001
715 METASTASES TO LUNG 1 0.0001
716 DELIRIUM 3 0.0001
717 ELECTROLYTE IMBALANCE 1 0.0001
718 CAESAREAN SECTION 1 0.0001
719 INJURY 6 0.0001
720 CHILLS 10 0.0001
721 COVID-19 PNEUMONIA 1 0.0001
722 DRUG ABUSE 7 0.0001
723 PRODUCTIVE COUGH 4 0.0001
724 HYPERLIPIDAEMIA 1 0.0001
725 RASH ERYTHEMATOUS 4 0.0001
726 MYELOSUPPRESSION 3 0.0001
727 PLEURAL EFFUSION 5 0.0001
728 NO THERAPEUTIC RESPONSE 1 0.0001
729 RESPIRATORY DEPRESSION 1 0.0001
730 HYPERCALCAEMIA 1 0.0001
731 VOMITING 38 0.0001
732 OSTEONECROSIS OF JAW 2 0.0001
733 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
734 ILEUS 1 0.0001
735 PEMPHIGUS 1 0.0001
736 DYSPNOEA 45 0.0001
737 DERMATITIS ALLERGIC 1 0.0001
738 BRAIN OEDEMA 1 0.0001
739 ABDOMINAL PAIN LOWER 2 0.0001
740 GASTRIC CANCER 2 0.0001
741 TREMOR 13 0.0001
742 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
743 GENITAL HAEMORRHAGE 1 0.0001
744 INFLAMMATION 4 0.0001
745 SKIN ULCER 2 0.0001
746 INJECTION SITE INDURATION 1 0.0001
747 RESPIRATORY TRACT INFECTION 2 0.0001
748 PLATELET COUNT INCREASED 1 0.0001
749 DISEASE PROGRESSION 9 0.0001
750 GASTRITIS 2 0.0001
751 ORAL CANDIDIASIS 1 0.0001
752 ABNORMAL BEHAVIOUR 3 0.0001
753 DRUG INTERACTION 12 0.0001
754 PNEUMONIA 24 0.0001
755 BLINDNESS 3 0.0001
756 DRUG TOXICITY 1 0.0001
757 IMPAIRED GASTRIC EMPTYING 1 0.0001
758 ACUTE HEPATIC FAILURE 1 0.0001
759 TREATMENT NONCOMPLIANCE 4 0.0001
760 CORONARY ARTERY OCCLUSION 1 0.0001
761 MEDICATION ERROR 4 0.0001
762 ORAL DISCOMFORT 1 0.0001
763 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
764 HUNGER 1 0.0001
765 APHONIA 1 0.0001
766 URTICARIA 12 0.0001
767 DEMENTIA 2 0.0001
768 TOXICITY TO VARIOUS AGENTS 12 0.0001
769 LYMPHOPENIA 1 0.0001
770 LETHARGY 4 0.0001
771 MENTAL DISORDER 3 0.0001
772 GASTROENTERITIS 1 0.0001
773 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
774 ACUTE MYOCARDIAL INFARCTION 2 0.0001
775 WHEEZING 4 0.0001
776 IMMUNODEFICIENCY 1 0.0001
777 PLATELET COUNT DECREASED 7 0.0001
778 OEDEMA PERIPHERAL 8 0.0001
779 INSURANCE ISSUE 1 0.0001
780 EMOTIONAL DISORDER 2 0.0001
781 ANKLE FRACTURE 1 0.0001
782 BLOOD CHOLESTEROL INCREASED 3 0.0001
783 COUGH 18 0.0001
784 ACUTE MYELOID LEUKAEMIA 1 0.0001
785 SWOLLEN TONGUE 2 0.0001
786 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
787 OBESITY 1 0.0001
788 METABOLIC ACIDOSIS 2 0.0001
789 DIARRHOEA 40 0.0001
790 CONFUSIONAL STATE 10 0.0001
791 COAGULOPATHY 1 0.0001
792 FACE OEDEMA 1 0.0001
793 HYPERSENSITIVITY 11 0.0001
794 ANGER 2 0.0001
795 URINARY TRACT INFECTION 10 0.0001
796 RASH MACULAR 2 0.0001
797 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
798 HYPERKALAEMIA 2 0.0001
799 DECREASED APPETITE 13 0.0001
800 MOBILITY DECREASED 4 0.0001
801 PELVIC PAIN 1 0.0001
802 RESTLESS LEGS SYNDROME 1 0.0001
803 DYSGEUSIA 4 0.0001
804 EYE SWELLING 2 0.0001
805 ERYTHEMA 11 0.0001
806 DYSPNOEA EXERTIONAL 2 0.0001
807 ASTHMA 6 0.0001
808 HALLUCINATION 4 0.0001
809 PROTEINURIA 1 0.0001
810 MUSCULOSKELETAL DISORDER 1 0.0001
811 DRUG PRESCRIBING ERROR 1 0.0001
812 EAR PAIN 1 0.0001
813 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
814 HAEMATOCRIT DECREASED 1 0.0001
815 WEIGHT DECREASED 14 0.0001
816 PREGNANCY 1 0.0000
817 CARDIAC FAILURE 4 0.0000
818 FULL BLOOD COUNT DECREASED 1 0.0000
819 PRURITUS 19 0.0000
820 VERTIGO 3 0.0000
821 NEUTROPHIL COUNT DECREASED 2 0.0000
822 BODY TEMPERATURE INCREASED 1 0.0000
823 OSTEOPOROSIS 2 0.0000
824 RIB FRACTURE 1 0.0000
825 PULMONARY HYPERTENSION 1 0.0000
826 MOUTH ULCERATION 1 0.0000
827 DRUG INEFFECTIVE 61 0.0000
828 DEEP VEIN THROMBOSIS 3 0.0000
829 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
830 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
831 FAECES DISCOLOURED 1 0.0000
832 PRODUCT DISPENSING ERROR 1 0.0000
833 PRODUCT PRESCRIBING ISSUE 1 0.0000
834 ALOPECIA 9 0.0000
835 MELAENA 1 0.0000
836 INFUSION RELATED REACTION 3 0.0000
837 FEBRILE NEUTROPENIA 3 0.0000
838 ANGIOEDEMA 2 0.0000
839 BLOOD PRESSURE DECREASED 3 0.0000
840 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
841 HEART RATE IRREGULAR 1 0.0000
842 NEPHROLITHIASIS 2 0.0000
843 SWELLING 4 0.0000
844 ARRHYTHMIA 2 0.0000
845 PULMONARY EMBOLISM 4 0.0000
846 THERAPY INTERRUPTED 3 0.0000
847 BLOOD GLUCOSE DECREASED 2 0.0000
848 LOCALISED INFECTION 1 0.0000
849 INTERSTITIAL LUNG DISEASE 2 0.0000
850 MENTAL IMPAIRMENT 1 0.0000
851 PRESYNCOPE 1 0.0000
852 NEURALGIA 1 0.0000
853 CEREBRAL INFARCTION 1 0.0000
854 LIVER INJURY 1 0.0000
855 DYSPEPSIA 4 0.0000
856 VISUAL IMPAIRMENT 5 0.0000
857 PNEUMONIA ASPIRATION 1 0.0000
858 DEPRESSION 9 0.0000
859 DIABETES MELLITUS 3 0.0000
860 HYPOPHAGIA 1 0.0000
861 SINUSITIS 4 0.0000
862 ABDOMINAL PAIN UPPER 8 0.0000
863 ANXIETY 11 0.0000
864 RASH GENERALISED 1 0.0000
865 DIPLOPIA 1 0.0000
866 SEDATION 1 0.0000
867 SPEECH DISORDER 2 0.0000
868 ANHEDONIA 1 0.0000
869 ASTHENIA 14 0.0000
870 DISTURBANCE IN ATTENTION 2 0.0000
871 MOOD ALTERED 1 0.0000
872 VISION BLURRED 5 0.0000
873 ARTHROPATHY 2 0.0000
874 FEELING COLD 1 0.0000
875 ABDOMINAL DISCOMFORT 6 0.0000
876 FLATULENCE 2 0.0000
877 INTENTIONAL DOSE OMISSION 1 0.0000
878 RED BLOOD CELL COUNT DECREASED 1 0.0000
879 CONVULSION 2 0.0000
880 HERPES ZOSTER 2 0.0000
881 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
882 SEIZURE 4 0.0000
883 BACK PAIN 8 0.0000
884 MYOCARDIAL INFARCTION 6 0.0000
885 DYSPHONIA 2 0.0000
886 ADVERSE DRUG REACTION 3 0.0000
887 BLOOD POTASSIUM DECREASED 1 0.0000
888 HEPATIC FAILURE 1 0.0000
889 EMOTIONAL DISTRESS 4 0.0000
890 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
891 EPILEPSY 1 0.0000
892 PAIN 20 0.0000
893 NERVOUS SYSTEM DISORDER 1 0.0000
894 PRODUCT USE ISSUE 6 0.0000
895 BONE DENSITY DECREASED 1 0.0000
896 DYSPHAGIA 3 0.0000
897 LOSS OF CONSCIOUSNESS 4 0.0000
898 NIGHT SWEATS 1 0.0000
899 ATRIAL FIBRILLATION 3 0.0000
900 SWELLING FACE 2 0.0000
901 OSTEONECROSIS 1 0.0000
902 EYE DISORDER 1 0.0000
903 HEART RATE INCREASED 3 0.0000
904 DEHYDRATION 4 0.0000
905 GAIT INABILITY 1 0.0000
906 MALAISE 13 0.0000
907 MYALGIA 5 0.0000
908 HAEMOGLOBIN DECREASED 3 0.0000
909 GASTRIC DISORDER 1 0.0000
910 NEOPLASM PROGRESSION 1 0.0000
911 HEART RATE DECREASED 1 0.0000
912 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
913 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
914 CEREBRAL HAEMORRHAGE 1 0.0000
915 INFECTION 4 0.0000
916 PANIC ATTACK 1 0.0000
917 RESTLESSNESS 1 0.0000
918 INJECTION SITE MASS 1 0.0000
919 INTESTINAL OBSTRUCTION 1 0.0000
920 COLITIS 1 0.0000
921 PLASMA CELL MYELOMA 1 0.0000
922 DISORIENTATION 1 0.0000
923 ABORTION SPONTANEOUS 1 0.0000
924 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
925 POLLAKIURIA 1 0.0000
926 PAIN IN EXTREMITY 7 0.0000
927 HYPERTENSION 5 0.0000
928 OSTEOARTHRITIS 1 0.0000
929 RECTAL HAEMORRHAGE 1 0.0000
930 MUSCULOSKELETAL STIFFNESS 2 0.0000
931 INSOMNIA 6 0.0000
932 DRY SKIN 3 0.0000
933 COLITIS ULCERATIVE 1 0.0000
934 DIZZINESS 11 0.0000
935 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
936 RENAL CANCER 1 0.0000
937 GAIT DISTURBANCE 4 0.0000
938 DEATH 18 0.0000
939 HEADACHE 13 0.0000
940 HYPOAESTHESIA 3 0.0000
941 DRY EYE 1 0.0000
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
943 FLUID RETENTION 1 0.0000
944 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
945 HAEMORRHAGE 2 0.0000
946 PARAESTHESIA 3 0.0000
947 DEPRESSED MOOD 1 0.0000
948 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
949 CONSTIPATION 4 0.0000
950 INFLUENZA 2 0.0000
951 NECK PAIN 1 0.0000
952 BLISTER 1 0.0000
953 RHEUMATOID ARTHRITIS 2 0.0000
954 EYE IRRITATION 1 0.0000
955 PRODUCT SUBSTITUTION ISSUE 1 0.0000
956 PALPITATIONS 2 0.0000
957 BONE PAIN 1 0.0000
958 CATARACT 1 0.0000
959 ILL-DEFINED DISORDER 1 0.0000
960 BLOOD GLUCOSE INCREASED 3 0.0000
961 RHINORRHOEA 1 0.0000
962 DEVICE EXPULSION 1 0.0000
963 AMNESIA 1 0.0000
964 BURNING SENSATION 1 0.0000
965 SKIN BURNING SENSATION 1 0.0000
966 BRONCHITIS 1 0.0000
967 WEIGHT INCREASED 3 0.0000
968 EPISTAXIS 1 0.0000
969 ACNE 1 0.0000
970 INJECTION SITE PAIN 4 0.0000
971 FATIGUE 10 0.0000
972 INJECTION SITE HAEMORRHAGE 1 0.0000
973 CARDIAC FAILURE CONGESTIVE 1 0.0000
974 PROSTATE CANCER 1 0.0000
975 DRY MOUTH 1 0.0000
976 DRUG WITHDRAWAL SYNDROME 1 0.0000
977 DEVICE ISSUE 1 0.0000
978 NASOPHARYNGITIS 2 0.0000
979 OROPHARYNGEAL PAIN 1 0.0000
980 BREAST CANCER 1 0.0000
981 MIGRAINE 1 0.0000
982 PRODUCT DOSE OMISSION ISSUE 3 0.0000
983 ILLNESS 1 0.0000
984 ABDOMINAL DISTENSION 1 0.0000
985 OVERDOSE 2 0.0000
986 FEELING ABNORMAL 2 0.0000
987 JOINT SWELLING 1 0.0000
988 PRODUCT QUALITY ISSUE 1 0.0000
989 MEMORY IMPAIRMENT 1 0.0000
990 ARTHRALGIA 3 0.0000
991 HOSPITALISATION 1 0.0000
992 DRUG DEPENDENCE 1 0.0000
993 NO ADVERSE EVENT 1 0.0000
994 MUSCLE SPASMS 1 0.0000
995 INCORRECT DOSE ADMINISTERED 1 0.0000
996 FALL 1 0.0000